about
Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in miceThe rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunitChronic restraint stress impairs neurogenesis and hippocampus-dependent fear memory in mice: possible involvement of a brain-specific transcription factor Npas4Noradrenergic refinement of glutamatergic neuronal circuits in the lateral superior olivary nucleus before hearing onset.Insular neural system controls decision-making in healthy and methamphetamine-treated ratsHeterozygous Disruption of Autism susceptibility candidate 2 Causes Impaired Emotional Control and Cognitive MemoryPrenatal NMDA receptor antagonism impaired proliferation of neuronal progenitor, leading to fewer glutamatergic neurons in the prefrontal cortexProstaglandin E receptor EP1 controls impulsive behavior under stress.Prenatal Nicotine Exposure Impairs the Proliferation of Neuronal Progenitors, Leading to Fewer Glutamatergic Neurons in the Medial Prefrontal Cortex.Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.Association of impaired neuronal migration with cognitive deficits in extremely preterm infants.Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortexDrug dependence, synaptic plasticity, and tissue plasminogen activator.Neuronal Per Arnt Sim (PAS) domain protein 4 (NPAS4) regulates neurite outgrowth and phosphorylation of synapsin I.Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice.Basic and translational research on proteinase-activated receptors: regulation of nicotine reward by the tissue plasminogen activator (tPA) - plasmin system via proteinase-activated receptor 1.Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules.Npas4 regulates Mdm2 and thus Dcx in experience-dependent dendritic spine development of newborn olfactory bulb interneurons.Molecular mechanism linking BDNF/TrkB signaling with the NMDA receptor in memory: the role of Girdin in the CNS.Stress increases DNA methylation of the neuronal PAS domain 4 (Npas4) gene.Phosphorylation Signals in Striatal Medium Spiny Neurons.The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients.Cytoskeletal regulation by AUTS2 in neuronal migration and neuritogenesis.Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial-cell-line-derived neurotrophic factor mutant mice.Phosphoproteomics of the Dopamine Pathway Enables Discovery of Rap1 Activation as a Reward Signal In Vivo.FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization.Matrix metalloproteinase-3 is a possible mediator of neurodevelopmental impairment due to polyI:C-induced innate immune activation of astrocytes.Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence.Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.Enhancement of immobility induced by repeated phencyclidine injection: association with c-Fos protein in the mouse brain.Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress.Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.SHATI/NAT8L regulates neurite outgrowth via microtubule stabilization.The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood.Behavioral abnormality and pharmacologic response in social isolation-reared mice.GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice.The long-lasting effects of cross-fostering on the emotional behavior in ICR mice.
P50
Q24654711-17DF6A5B-E199-4237-B610-E4CE7EB5FE33Q28588421-BA9C9591-4367-4210-A4E5-AAF7A44E94B2Q28589454-5908F3AA-077B-4C8A-B6AB-17B5A4551723Q28591306-2AB8761E-CE7B-4E28-9DCA-9B8E7F0CC023Q30375353-AE57828B-E72B-4729-8B3F-031D5DEF92A5Q30393339-0A555395-5541-4434-BB51-4376C983300BQ30393988-36AB7469-F1C0-4D05-9A28-64EBDB634590Q30455076-E032F5AE-559E-4229-9B29-9E349A31CCC7Q30476333-0140FBE7-EF53-42C9-A94D-1386ABE47E76Q30830261-D5184524-701F-4060-A704-F3881FEECFF2Q31997655-AD9EB5D2-7006-48B8-A2EA-1015597E4190Q33703210-0671F7F0-5AE8-4CA6-A788-3C1F6C57B415Q35721013-D1DFA176-FC10-4BEC-9658-4EA231E6232FQ36026364-1E60AEFE-3BC3-486A-9301-F5203DEE19FFQ36562081-5098878E-A92A-46C5-9847-558A046C4C72Q37163288-8E6B8100-3A6D-4D9F-9C21-536B41B008ABQ37355508-7967F24A-50CD-4E44-ADC9-1E33E2014F5DQ38059046-80A61EFA-F7AB-47B1-93C6-F749244BC9BFQ38305290-C1903AB9-2BFC-4890-A950-3F014FA49FFDQ38755172-F35FFF28-E524-4E9D-BCBD-E1C7A5E617DEQ38848138-1CF182E5-BEE5-4298-9E72-7EE759430F97Q38933545-6EA20CC1-F10C-4B3C-B3D8-B4BEAF1016DAQ39721788-53EB1631-723B-42E9-930E-D993B8EFC54DQ40036346-4DC281EA-02D6-4C56-857B-16383E05EEDDQ40159845-FEF9A836-48E5-40E3-A25F-CD3251827D82Q40954497-6E432B47-95A4-49BA-9D34-1CE5C5414587Q41950782-DAB27D0D-5AC2-4A65-BC24-E06906D9E98AQ42233788-DBCC3843-39A1-4A58-942A-D88CD7AE9E93Q42449226-89408878-F3FC-4B28-8B22-D5DB573D3F5FQ43254779-3F479C00-9913-4157-88FD-34CB2757DC74Q43651587-8AC1F5AC-A30D-45E9-A7A8-65717AD2C114Q44244845-C2C29CE5-A40A-47D4-83B8-3BB7ABBB11A3Q44785509-FCAF202B-5557-4148-84B8-B2BAC2B217DEQ44789464-0BEFA60E-F59A-4697-9420-949281143345Q45230317-9546B9A4-6EA5-4A3C-A3AB-144295E43477Q45917384-FF502280-AB4F-421D-9A1F-27D93A6A4026Q46008944-F143FAB0-2935-4683-A9B1-90CEEFAB063AQ46008956-1282A24A-950F-4C89-8E27-83BE5028A548Q46231837-032D97D7-6BC3-49FF-9190-A80D040F0B01Q46232795-6E9B35CF-1B4D-4FE0-BD17-7926259D8046
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Taku Nagai
@ast
Taku Nagai
@en
Taku Nagai
@es
Taku Nagai
@nl
Taku Nagai
@sl
type
label
Taku Nagai
@ast
Taku Nagai
@en
Taku Nagai
@es
Taku Nagai
@nl
Taku Nagai
@sl
prefLabel
Taku Nagai
@ast
Taku Nagai
@en
Taku Nagai
@es
Taku Nagai
@nl
Taku Nagai
@sl
P108
P1053
I-7507-2014
P106
P31
P3829
P496
0000-0001-5050-7748